Bosch, Francesc ORCID: 0000-0001-9241-2886 and Hallek, Michael (2018). Venetoclax after idelalisib: relevant progress for CLL. Blood, 131 (15). S. 1632 - 1636. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Bosch, FrancescUNSPECIFIEDorcid.org/0000-0001-9241-2886UNSPECIFIED
Hallek, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-189396
DOI: 10.1182/blood-2018-02-826396
Journal or Publication Title: Blood
Volume: 131
Number: 15
Page Range: S. 1632 - 1636
Date: 2018
Publisher: AMER SOC HEMATOLOGY
Place of Publication: WASHINGTON
ISSN: 1528-0020
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
CHRONIC LYMPHOCYTIC-LEUKEMIA; OFATUMUMAB; IBRUTINIBMultiple languages
HematologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/18939

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item